Real‐World Treatment Patterns and Healthcare Costs in Patients with Psoriatic Arthritis Treated with Ixekizumab: A Retrospective Study

OBJECTIVE: To describe adherence, persistence, discontinuation, restarting, switching, dosing, and health care costs among patients with psoriatic arthritis (PsA) treated with ixekizumab (IXE). METHODS: MarketScan administrative claims databases were used to select adults (≥18 years) initiating IXE...

Descripción completa

Detalles Bibliográficos
Autores principales: Murage, Mwangi J., Princic, Nicole, Park, Julie, Malatestinic, William, Zhu, Baojin, Atiya, Bilal, Kern, Scott A., Stenger, Keri B., Sprabery, Aubrey Trevelin, Ogdie, Alexis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672175/
https://www.ncbi.nlm.nih.gov/pubmed/34550647
http://dx.doi.org/10.1002/acr2.11347

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672175/
https://www.ncbi.nlm.nih.gov/pubmed/34550647
http://dx.doi.org/10.1002/acr2.11347

Ejemplares similares